Sriveda Boyalakuntla, Riten Kumar
Dec 14, 2025, 12:56
Mentored by Riten Kumar, Sriveda Boyalakuntla Presents Key Research on Infection-Associated Thrombosis at ASH25
Kishore Boyalakuntla, GM and CPO at Re:Build Cadonix, reposted Riten Kumar’s post on LinkedIn:
“Congrats Sriveda Boyalakuntla on the work related to infection associated thrombosis. It is special to be mentored by Riten Kumar and the team at Boston Children’s Hospital.”
Quoting Riten Kumar’s post:
“Last day at ASH25 – interesting subgroup analysis from the RENOVE trial, increased CRNM bleeding with apixaban and aspirin, but not NSAIDs and Sriveda BoyalaKuntla’s excellent presentation on infection associated thrombosis, finished off with trainees – past, present and future!”
Get the latest on Hemostasis Today.
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy
-
Dec 14, 2025, 16:06Dr Abdul Mannan: What’s Your Approach to Diagnosing Iron Deficiency in Tricky Cases?